Cargando…
Peptide Inhibitor of Complement C1 (PIC1) Rapidly Inhibits Complement Activation after Intravascular Injection in Rats
The complement system has been increasingly recognized to play a pivotal role in a variety of inflammatory and autoimmune diseases. Consequently, therapeutic modulators of the classical, lectin and alternative pathways of the complement system are currently in pre-clinical and clinical development....
Autores principales: | Sharp, Julia A., Hair, Pamela S., Pallera, Haree K., Kumar, Parvathi S., Mauriello, Clifford T., Nyalwidhe, Julius O., Phelps, Cody A., Park, Dalnam, Thielens, Nicole M., Pascal, Stephen M., Chen, Waldon, Duffy, Diane M., Lattanzio, Frank A., Cunnion, Kenji M., Krishna, Neel K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511006/ https://www.ncbi.nlm.nih.gov/pubmed/26196285 http://dx.doi.org/10.1371/journal.pone.0132446 |
Ejemplares similares
-
Inhibition of Myeloperoxidase Activity in Cystic Fibrosis Sputum by Peptide Inhibitor of Complement C1 (PIC1)
por: Hair, Pamela S., et al.
Publicado: (2017) -
Inhibition of complement activation, myeloperoxidase, NET formation and oxidant activity by PIC1 peptide variants
por: Hair, Pamela S., et al.
Publicado: (2019) -
Hyperglycemia Inhibits Complement-Mediated Immunological Control of S. aureus in a Rat Model of Peritonitis
por: Mauriello, Clifford T., et al.
Publicado: (2014) -
Peptide Inhibitor of Complement C1 (PIC1) demonstrates antioxidant activity via single electron transport (SET) and hydrogen atom transfer (HAT)
por: Gregory Rivera, Magdielis, et al.
Publicado: (2018) -
Classical complement pathway inhibition reduces brain damage in a hypoxic ischemic encephalopathy animal model
por: Kumar, Parvathi, et al.
Publicado: (2021)